Literature DB >> 14988197

Synthesising licensing data to assess drug safety.

Klim McPherson1, Elina Hemminki.   

Abstract

Mesh：

Year:  2004        PMID： 14988197      PMCID： PMC351857          DOI： 10.1136/bmj.328.7438.518

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  16 in total

1.  Balancing benefits and harms in health care.

Authors:  Luis Gabriel Cuervo; Mike Clarke
Journal:  BMJ       Date:  2003-07-12

2.  Postmenopausal hormone therapy: a reversal of fortune.

Authors:  Karin B Michels; JoAnn E Manson
Journal:  Circulation       Date:  2003-04-15       Impact factor: 29.690

3.  Intellectual property, drug licensing, freedom of information, and public health.

Authors:  I Roberts; A L Po; I Chalmers
Journal:  Lancet       Date:  1998-08-29       Impact factor: 79.321

4.  Value of drug-licensing documents in studying the effect of postmenopausal hormone therapy on cardiovascular disease.

Authors:  E Hemminki; K McPherson
Journal:  Lancet       Date:  2000-02-12       Impact factor: 79.321

5.  The case for recording events in clinical trials.

Authors:  D C Skegg; R Doll
Journal:  Br Med J       Date:  1977-12-10

6.  Selection to postmenopausal therapy by women's characteristics.

Authors:  E Hemminki; M Malin; P Topo
Journal:  J Clin Epidemiol       Date:  1993-03       Impact factor: 6.437

Review 7.  Evidence from randomised trials on the long-term effects of hormone replacement therapy.

Authors:  Valerie Beral; Emily Banks; Gillian Reeves
Journal:  Lancet       Date:  2002-09-21       Impact factor: 79.321

8.  Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project.

Authors: 
Journal:  N Engl J Med       Date:  1980-10-30       Impact factor: 91.245

9.  Menopause and risk factors for coronary heart disease.

Authors:  K A Matthews; E Meilahn; L H Kuller; S F Kelsey; A W Caggiula; R R Wing
Journal:  N Engl J Med       Date:  1989-09-07       Impact factor: 91.245

10.  Estrogen plus progestin and the risk of coronary heart disease.

Authors:  JoAnn E Manson; Judith Hsia; Karen C Johnson; Jacques E Rossouw; Annlouise R Assaf; Norman L Lasser; Maurizio Trevisan; Henry R Black; Susan R Heckbert; Robert Detrano; Ora L Strickland; Nathan D Wong; John R Crouse; Evan Stein; Mary Cushman
Journal:  N Engl J Med       Date:  2003-08-07       Impact factor: 91.245
View more
  8 in total

1.  Benefits and harms of drug treatments.

Authors:  Jan P Vandenbroucke
Journal:  BMJ       Date:  2004-07-03

2.  What doesn't work and how to show it.

Authors:  Phil Alderson; Trish Groves
Journal:  BMJ       Date:  2004-02-28

3.  Transparency in drug regulation: mirage or oasis?

Authors:  Joel Lexchin; Barbara Mintzes
Journal:  CMAJ       Date:  2004-11-23       Impact factor: 8.262

Review 4.  Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives.

Authors:  Nancy Krieger; Ilana Löwy; Robert Aronowitz; Judyann Bigby; Kay Dickersin; Elizabeth Garner; Jean-Paul Gaudillière; Carolina Hinestrosa; Ruth Hubbard; Paula A Johnson; Stacey A Missmer; Judy Norsigian; Cynthia Pearson; Charles E Rosenberg; Lynn Rosenberg; Barbara G Rosenkrantz; Barbara Seaman; Carlos Sonnenschein; Ana M Soto; Joe Thornton; George Weisz
Journal:  J Epidemiol Community Health       Date:  2005-09       Impact factor: 3.710

Review 5.  Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview.

Authors:  Su Golder; Yoon K Loke; Martin Bland
Journal:  PLoS Med       Date:  2011-05-03       Impact factor: 11.069

6.  Non interventional drug studies in oncology: Why we need them?

Authors:  Divya Mishra; Jesal Vora
Journal:  Perspect Clin Res       Date:  2010-10

7.  Editor'S comment.

Authors:  Rama Vaidya; Rashmi Shah
Journal:  J Midlife Health       Date:  2010-07

8.  Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis.

Authors:  Monica Bolton; Alex Hodkinson; Shivani Boda; Alan Mould; Maria Panagioti; Sarah Rhodes; Lisa Riste; Harm van Marwijk
Journal:  BMC Med       Date:  2019-01-15       Impact factor: 8.775
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.